开发用于瘤性TRK融合的向降解的PROTACs
Saurav Kumar1, Jiewei Jiang2, Mia S Donald-Paladino1
1Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
bioRxiv : the preprint server for biology
|July 16, 2025
概括
研究人员开发了新型降解剂 (PROTACs),以准癌症中的TRK融合. 化合物JWJ-01-378有效降解TPM3-TRKA,抑制癌细胞生长,并提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 染色体转位会产生致癌的TRK融合,导致各种癌症.
- 现有的TRK抑制剂面临抗药性,需要新的治疗方法.
- 有针对性的蛋白质降解提供了一个有希望的战略,以克服抵抗.
研究的目的:
- 开发用于TRK融合的新型异构生物功能小分子降解剂 (PROTACs).
- 为了评估一种新的TRK向PROTAC的疗效和选择性,JWJ-01-378.
主要方法:
- 通过将恩特雷克提尼布与thalidomide结合而设计和合成PROTACs.
- 评估JWJ-01-378通过ubiquitin-proteasome系统对TPM3-TRKA的降解.
- 蛋白质组学分析以确认选择性和下游信号和细胞活性的评估.
主要成果:
- JWJ-01-378有效降解了TPM3-TRKA的融合蛋白.
- 降解是有选择的,观察到的目标外效应最小.
- JWJ-01-378抑制了下游的信号传输,并降低了癌细胞的活力.
结论:
- 使用PROTACs降解TRK融合是一种可行的治疗策略.
- JWJ-01-378显示了TPM3-TRKA的强大和选择性降解.
- 这种方法扩大了TRK融合驱动癌症的治疗选择.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Enzyme-linked Receptors
80.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.0K
Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Receptor Tyrosine Kinases
14.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K


